Coronavirus
Spain to Keep Registry of People Who Refuse COVID-19 Vaccination
Spain will set up a registry of people who refuse to be vaccinated against the new coronavirus and share it with other European Union member states. Keep Reading
Coronavirus
FAA: Pilots and Air Traffic Controllers May Receive BioNTech/Pfizer Vaccine, With Precaution
The agency will require aviation professionals with medical certifications or medical clearances to observe a period of 48 hours following the administration of this vaccine before conducting safety-sensitive aviation duties, such as flying or controlling air traffic. Keep Reading
Coronavirus
2020 Vaccine Supplies Fall Short of Operation Warp Speed Promise
Instead of the delivery of 300 million or so doses of vaccine immediately after emergency-use approval and before the end of 2020 as the Trump administration had originally promised, current plans call for availability of around a tenth of that, or 35 to 40 million doses. Keep Reading
Coronavirus
Pfizer/BioNTech Vaccine Available Across U.K. Next Week
The British government has on December 2 accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency to approve Pfizer/BioNTech’s COVID-19 vaccine for use. Keep Reading
Coronavirus
ICE Pivots to Combat COVID-19 Vaccine Fraud with Launch of Operation Stolen Promise 2.0
U.S. Immigration and Customs Enforcement (ICE) is preparing for a surge in anticipated fraud by criminal networks related to COVID-19 vaccines and treatments. Keep Reading
Coronavirus
Oxford University and AstraZeneca Announce COVID-19 Vaccine
The vaccine can be stored, transported and handled at normal refrigerated conditions (2-8 degrees Celsius/ 36-46 degrees Fahrenheit) for at least six months and administered within existing healthcare settings. Keep Reading
Critical Infrastructure Security & Resilience Month
Are We Prepared for Vaccination Distribution?
The new IATA Guidance for Vaccine and Pharmaceutical Logistics and Distribution provides recommendations for governments and the logistics supply chain in preparation for what will be the largest and most complex global logistics operation ever undertaken. Keep Reading
Coronavirus
GAO Calls for More Transparency on COVID-19 Emergency Use Authorizations
Representatives of state and local public health officials and healthcare providers noted several areas where additional information and assistance may be necessary. Keep Reading
Coronavirus
Moderna’s COVID-19 Vaccine Records 94.5 Percent Efficacy
Preliminary analysis suggests a broadly consistent safety and efficacy profile across all evaluated subgroups. Keep Reading
Coronavirus
Who Is Behind the New COVID-19 Vaccine?
Scientists Ugur Sahin and Ozlem Tureci have dedicated their lives to the field of oncology and infectious diseases, and spent years pioneering personalized immunotherapy treatments for cancer. Keep Reading
Coronavirus
Pfizer and BioNTech Announce Their COVID-19 Vaccine is More Than 90% Effective
Pfizer says the first set of results from the Phase 3 vaccine trial provides the initial evidence of the vaccine’s ability to prevent COVID-19. Keep Reading
National Preparedness Month
Governments Urged to Plan Now for ‘Mammoth and Complex’ Task of Vaccine Distribution
Imagine the catastrophic effects should a vulnerability in the supply chain allow vaccines destined for millions of people to be sabotaged and contaminated. Keep Reading